.png){kind=icon}
Return
Efficient Augmented Intelligence Framework for Bladder Lesion Detection
.png){kind=icon}
PRE
AI
DOI：10.1200/CCI.23.00031.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
PURPOSE Development of intelligence systems for bladder lesion detection is cost intensive. An efficient strategy to develop such intelligence solutions is needed. MATERIALS AND METHODS We used four deep learning models (ConvNeXt, PlexusNet, MobileNet, and SwinTransformer) covering a variety of model complexity and efficacy. We trained these models on a previously published educational cystoscopy atlas (n = 312 images) to estimate the ratio between normal and cancer scores and externally validated on cystoscopy videos from 68 cases, with region of interest (ROI) pathologically confirmed to be benign and cancerous bladder lesions (ie, ROI). The performance measurement included specificity and sensitivity at frame level, frame sequence (block) level, and ROI level for each case. RESULTS Specificity was comparable between four models at frame (range, 30.0%-44.8%) and block levels (56%-67%). Although sensitivity at the frame level (range, 81.4%-88.1%) differed between the models, sensitivity at the block level (100%) and ROI level (100%) was comparable between these models. MobileNet and PlexusNet were computationally more efficient for real-time ROI detection than ConvNeXt and SwinTransformer. CONCLUSION Educational cystoscopy atlas and efficient models facilitate the development of real-time intelligence system for bladder lesion detection.
Keywords:
CYSTOSCOPY
CANCER
HEXAMINOLEVULINATE
RECURRENCE
Journal
J
IF:
2.8
Papers:
669
Citations:
2.4K
Organization
Cited Papers
Desempenho de crianças do ensino fundamental na solução de problemas aritméticos<A NAME="top"></A>
OAAI
OAAIShareSaveA nationwide prospective cohort study on return to gainful occupation after stroke in Denmark 1996–2006.png)
BMJ Open
OAAI
BMJ OpenIF0
OAAIShareSaveShareSaveTreatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?BJU INTERNATIONAL
BJU INTERNATIONALIF4.4
PREAI
ShareSaveShareSaveShareSave
View more